Why Moderna Inc (NASDAQ: MRNA) At $151.01 Is Worth Your Money?

Moderna Inc (NASDAQ:MRNA) does about 4.09M shares in volume on a normal day but saw 2519117 shares change hands in Friday’s trading. The company now has a market cap of 57.87B USD. Its current market price is $151.01, marking a decrease of -2.38% compared to the previous close of $154.69. The 52 week high reached by this stock is $170.47 whilst the lowest price level in 52 weeks is $62.55.

Moderna Inc (MRNA) has a 20-day trading average at $144.67 and the current price is -11.42% off the 52-week high compared with 141.42% distance from its 52-week low. The 50-day simple moving average of the closing price is $123.46 and its 200-day simple moving average is $102.10. If we look at the stock’s price movements over the week, volatility stands at 5.70%, which increases to 6.39% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 59.36 to suggest the stock is neutral.

The consensus objective for the share price is $142.11, suggesting that the stock has a potential downside of -6.26% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on February 26, 2024 when HSBC Securities downgraded the stock to “Reduce” and issued a price target of between $75 and $86. Oppenheimer upgraded the stock to “Outperform” from Perform on January 02, 2024 at a price target of $142. Canaccord Genuity initiated its price target at $82.

Moderna Inc (MRNA) stock is up 5.93% over the week and 23.89% over the past month. Its price is 51.85% year-to-date and 20.22% over the past year.

To reach the target analysts have set, the stock logically needs to shrink -6.26 percent from here.

The company has a return on investment of -42.54% and return on equity of -37.68%. The beta has a value of 1.70. Price to book ratio is 4.51 and price to sales ratio is 11.25.